Skip to content

Challenge Searches For Discontinued Drugs To Treat Rare Diseases

February 19, 2013

InnoCentive is a “global leader in crowdsourcing innovation problems to the world’s smartest people who compete to provide ideas and solutions to important business, social, policy, scientific, and technical challenges.” For more than 10 years, top companies and organizations, such as AARP, Booz Allen Hamilton, Cleveland Clinic, Eli Lilly & Company, Procter & Gamble, and Thomson Reuters partner with InnoCentive to generate new ideas and solve problems faster and cost effectively.

A current “Challenge” involving orphan or rare diseases and “repurposing” discontinued pharmaceuticals is posted on InnoCentive’s website on February 8, 2013. The deadline date is March 11, 2013, and has an award. The “Seeker” for this “Challenge” is an unnamed biopharmaceutical company with expertise in developing orphan drugs for rare diseases, who “desires proposals for pharmaceuticals that have been discontinued in clinical development but that could have potential to treat a non-oncology rare disease”.

Please see InnoCentive’s website for this Challenge titled, “Treating Orphan Diseases: Repurposing Discontinued Pharmaceuticals” for additional information.


InnoCentive on Facebook February 15, 2013 article titled, “Challenge Seeks Discontinued Drugs To Treat Rare Diseases”.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: